Characteristics associated with maintenance of mean A1C<6.5% in people with dysglycemia in the ORIGIN trial.

OBJECTIVE: To assess the success and baseline predictors of maintaining glycemic control for up to 5 years of therapy using basal insulin glargine or standard glycemic care in people with dysglycemia treated with zero or one oral glucose-lowering agents. RESEARCH DESIGN AND METHODS: Data from 12,537... View More